Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Robert F van Es1, Jan J C Jonker, Freek W A Verheugt

  • 1Julius Centre for General Practice and Patient Oriented Research, University Medical Centre Utrecht, Netherlands.

PubMed

Insights

Oral anticoagulants or combination therapy with aspirin and anticoagulants are more effective than aspirin alone for reducing cardiovascular events after myocardial infarction. Combination therapy increased minor bleeding risk.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Aspirin and oral anticoagulants are used to prevent recurrent ischemic events post-myocardial infarction.
  • Optimal long-term antiplatelet and anticoagulant strategies require further investigation.
  • Balancing efficacy and bleeding risk is crucial in managing acute coronary events.

Purpose of the Study:

  • To compare the long-term effectiveness of aspirin, oral anticoagulants, and combination therapy after acute coronary events.
  • To assess the safety profile, particularly bleeding risk, associated with each treatment strategy.

Main Methods:

  • A randomized open-label trial involving 999 patients across 53 sites.
  • Patients were assigned to low-dose aspirin, high-intensity oral anticoagulation, or combined low-dose aspirin and moderate-intensity oral anticoagulation.
  • Follow-up extended to 26 months, with the primary endpoint being myocardial infarction, stroke, or death.

Main Results:

  • Combination therapy (aspirin + anticoagulants) and oral anticoagulants alone showed greater efficacy in reducing the primary endpoint compared to aspirin alone (p=0.03 and p=0.0479, respectively).
  • Major bleeding rates were similar across all groups.
  • Minor bleeding occurred more frequently in the combination therapy group (15%) compared to aspirin (5%) or anticoagulants alone (8%).

Conclusions:

  • High-intensity oral anticoagulants or combined aspirin and moderate-intensity oral anticoagulants are more effective than aspirin alone for reducing cardiovascular events and death post-acute coronary events.
  • While effective, combination therapy is associated with an increased risk of minor bleeding.
  • Treatment decisions should weigh the benefits of reduced ischemic events against the increased risk of bleeding.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...